Search Results - "Yamashita, Takeshi"

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation by Okumura, Ken, Akao, Masaharu, Yoshida, Tetsuro, Kawata, Masahito, Okazaki, Osamu, Akashi, Shintaro, Eshima, Kenichi, Tanizawa, Kimihiko, Fukuzawa, Masayuki, Hayashi, Takuya, Akishita, Masahiro, Lip, Gregory Y.H, Yamashita, Takeshi

“…Elderly patients with atrial fibrillation who were not appropriate candidates for standard doses of oral anticoagulants because of a high risk of bleeding were…”
Get full text

Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF registry sub-cohort analysis by Suzuki, Shinya, Yamashita, Takeshi, Akao, Masaharu, Okumura, Ken

“…Purpose To investigate the distribution of plasma apixaban levels and their relationships with clinical outcomes in elderly patients with atrial fibrillation…”
Get full text

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials by Ruff, Christian T, Dr, Giugliano, Robert P, MD, Braunwald, Eugene, Prof, Hoffman, Elaine B, PhD, Deenadayalu, Naveen, MPH, Ezekowitz, Michael D, Prof, Camm, A John, Prof, Weitz, Jeffrey I, Prof, Lewis, Basil S, Prof, Parkhomenko, Alexander, Prof, Yamashita, Takeshi, Prof, Antman, Elliott M, Prof

“…Summary Background Four new oral anticoagulants compare favourably with warfarin for stroke prevention in patients with atrial fibrillation; however, the…”
Get full text

Evaluation of flood damage reduction throughout Japan from adaptation measures taken under a range of emissions mitigation scenarios by Yamamoto, Tao, Kazama, So, Touge, Yoshiya, Yanagihara, Hayata, Tada, Tsuyoshi, Yamashita, Takeshi, Takizawa, Hiroyuki

“…This study aimed to evaluate the impact of climate change on flood damage and the effects of mitigation measures and combinations of multiple adaptation…”
Get full text

Epstein-Barr Virus Dacryoadenitis in a Young Woman by Watanabe, Tamami, Yamashita, Takeshi, Sugawara, Hitoshi

Get full text

Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis by Akao, Masaharu, Yamashita, Takeshi, Suzuki, Shinya, Okumura, Ken

“…Randomized clinical trials demonstrated the efficacy and safety of apixaban in preventing stroke in patients with atrial fibrillation (AF). However, data on…”
Get full text

Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis?　– Reply by Yamashita, Takeshi

Get full text

Predictors for a high apixaban level in elderly patients with atrial fibrillation prescribed reduced dose of apixaban by Suzuki, Shinya, Yamashita, Takeshi, Akao, Masaharu, Okumura, Ken

Get full text

A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J‐ELD AF Registry) by Okumura, Ken, Yamashita, Takeshi, Suzuki, Shinya, Akao, Masaharu

“…Background A global, randomized clinical trial indicated the efficacy and safety of apixaban in stroke prevention in patients with nonvalvular atrial…”
Get full text

Minimally invasive esophagectomy and radical lymph node dissection without recurrent laryngeal nerve paralysis by Otsuka, Koji, Murakami, Masahiko, Goto, Satoru, Ariyoshi, Tomotake, Yamashita, Takeshi, Saito, Akira, Kohmoto, Masahiro, Kato, Rei, Lefor, Alan Kawarai, Aoki, Takeshi

“…Background We introduce a novel operative technique to dissect lymph nodes adjacent to the recurrent laryngeal nerve, referred to as the “native tissue…”
Get full text

Recent Mortality and Morbidity Rates of Japanese Atrial Fibrillation Patients: Racial Differences and Risk Stratification by Yamashita, Takeshi

“…Atrial fibrillation (AF) is becoming an epidemiologically important syndrome among the developed countries. Although racial differences exist with regard to AF…”
Get full text

Incidence of Ischemic Stroke in Japanese Patients With Atrial Fibrillation Not Receiving Anticoagulation Therapy: Pooled Analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry by Suzuki, Shinya, Yamashita, Takeshi, Okumura, Ken, Atarashi, Hirotsugu, Akao, Masaharu, Ogawa, Hisashi, Inoue, Hiroshi

“…Background:The incidence rate of ischemic stroke in Japanese non-valvular atrial fibrillation (NVAF) patients without anticoagulation therapy remains…”
Get full text

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013): Digest Version by Group, JCS Joint Working

“…(Circ J 2014; 78: 1997–2021)…”
Get full text

Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M by Abe, Hajime, Takeda, Norihiko, Isagawa, Takayuki, Semba, Hiroaki, Nishimura, Satoshi, Morioka, Masaki Suimye, Nakagama, Yu, Sato, Tatsuyuki, Soma, Katsura, Koyama, Katsuhiro, Wake, Masaki, Katoh, Manami, Asagiri, Masataka, Neugent, Michael L., Kim, Jung-whan, Stockmann, Christian, Yonezawa, Tomo, Inuzuka, Ryo, Hirota, Yasushi, Maemura, Koji, Yamashita, Takeshi, Otsu, Kinya, Manabe, Ichiro, Nagai, Ryozo, Komuro, Issei

“…The fibrogenic response in tissue-resident fibroblasts is determined by the balance between activation and repression signals from the tissue microenvironment…”
Get full text

Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment by Koretsune, Yukihiro, Yamashita, Takeshi, Kimura, Tetsuya, Fukuzawa, Masayuki, Abe, Kenji, Yasaka, Masahiro

“…Background:The short-term safety and plasma concentrations of edoxaban 15 mg once daily in Japanese patients with non-valvular atrial fibrillation (NVAF) and…”
Get full text

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial by Kato, Eri Toda, Giugliano, Robert P., Ruff, Christian T., Koretsune, Yukihiro, Yamashita, Takeshi, Kiss, Robert Gabor, Nordio, Francesco, Murphy, Sabina A., Kimura, Tetsuya, Jin, James, Lanz, Hans, Mercuri, Michele, Braunwald, Eugene, Antman, Elliott M.

“…Background Elderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified…”
Get full text

Impact of frailty and mild cognitive impairment on delirium after cardiac surgery in older patients by Itagaki, Atsunori, Sakurada, Koji, Matsuhama, Minoru, Yajima, Junji, Yamashita, Takeshi, Kohzuki, Masahiro

“…•Combined prevalence of frailty and mild cognitive impairment (MCI) was 27% in older cardiac surgery patients.•Physical frailty or MCI alone had no significant…”
Get full text

Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation　– An ENGAGE AF-TIMI 48 Subanalysis by Yamashita, Takeshi, Koretsune, Yukihiro, Yang, Yuejin, Chen, Shih-Ann, Chung, Namsik, Shimada, Yuichi J., Kimura, Tetsuya, Miyazaki, Koichi, Abe, Kenji, Mercuri, Michele, Ruff, Christian T., Giugliano, Robert P.

“…Background:In the multinational, double-blind, double-dummy ENGAGE AF-TIMI 48 phase 3 study, once-daily edoxaban was non-inferior to warfarin for prevention of…”
Get full text

Multi-scale Simulations in a Catalytic Reactor Considering Three-dimensional Pellet Geometry by Yoichi Takagishi, Ryohei Baba, Takeshi Yamashita, Wataru Adachi

“…Catalytic reactors that convert carbon dioxide into methanol are one of the key technologies in carbon recycling. Various numerical simulations have been…”
Get full text

Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial by Akao, Masaharu, Yamashita, Takeshi, Fukuzawa, Masayuki, Hayashi, Takuya, Okumura, Ken

“…The ELDERCARE-AF trial showed that low-dose edoxaban benefits elderly patients with nonvalvular atrial fibrillation considered ineligible for standard oral…”
Get full text